Journals Investigate Possible Misconduct in Heart Research

Scientific publishers get involved in a scandal at Temple University that has so far produced one retraction for image manipulation, a university-led investigation, and a lawsuit by one of the researchers involved.

Written byCatherine Offord
| 2 min read
Temple University flag flying in front of a university building
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Three medical journals have launched investigations into papers published by researchers at Temple University following allegations of data manipulation, Reuters reports today (September 13).

The studies, most of which were supervised by cardiovascular scientist Abdel Karim Sabri, are already the subject of a misconduct investigation launched by Temple in late 2020 at the request of the US Office of Research Integrity (ORI).

Temple’s senior associate dean of research, Steven Houser—himself a coauthor on many of the studies—filed a lawsuit last year aiming to limit the scope of the university’s inquiry, although that effort has so far proved unsuccessful. The involvement of the journals seems likely to draw more scrutiny to the problematic papers, according to Reuters.

The ORI asked Temple to conduct its own investigation in 2020 after reviewing criticisms of multiple papers on the online post-publication review forum PubPeer. The institution’s inquiry concerns 15 papers published since 2008, nine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies